Treatment with the Smallpox Antiviral Tecovirimat (ST-246) Alone or in Combination with ACAM2000 Vaccination Is Effective as a Postsymptomatic Therapy for Monkeypox Virus Infection

ABSTRACT The therapeutic efficacies of smallpox vaccine ACAM2000 and antiviral tecovirimat given alone or in combination starting on day 3 postinfection were compared in a cynomolgus macaque model of lethal monkeypox virus infection. Postexposure administration of ACAM2000 alone did not provide any protection against severe monkeypox disease or mortality. In contrast, postexposure treatment with tecovirimat alone or in combination with ACAM2000 provided full protection. Additionally, tecovirimat treatment delayed until day 4, 5, or 6 postinfection was 83% (days 4 and 5) or 50% (day 6) effective.

[1]  I. Damon,et al.  The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data. , 2013, Vaccine.

[2]  R. Holman,et al.  Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox) , 2013, Antimicrobial Agents and Chemotherapy.

[3]  R. Jordan,et al.  Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox Virus , 2011, Journal of Virology.

[4]  Kevin F. Jones,et al.  Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice. , 2010, Vaccine.

[5]  Kevin F. Jones,et al.  ST-246 Inhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic Disease Manifestation , 2009, Antimicrobial Agents and Chemotherapy.

[6]  Chelsea M. Byrd,et al.  ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification , 2009, Antimicrobial Agents and Chemotherapy.

[7]  R. Jordan,et al.  In Vitro Efficacy of ST246 against Smallpox and Monkeypox , 2008, Antimicrobial Agents and Chemotherapy.

[8]  R. Jordan,et al.  Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model. , 2008, Antiviral research.

[9]  Kevin F. Jones,et al.  Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination , 2007, Vaccine.

[10]  R. Jordan,et al.  An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge , 2005, Journal of Virology.

[11]  F. Fenner.  Smallpox and its eradication , 1988 .